Prognostic significance of AKT/mTOR signaling in advanced neuroendocrine tumors treated with somatostatin analogs

INTRODUCTION: Somatostatin analogs (SSAs) are used as part of standard treatment for advanced neuroendocrine tumors (NETs). The mechanisms behind the antiproliferative action of SSAs remain largely unknown, but a connection with the mammalian target of rapamycin (mTOR) signaling pathway has been sug...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandes, Isabel, Pacheco, Teresa R, Costa, Adília, Santos, Ana C, Fernandes, Ana R, Santos, Mara, Oliveira, António G, Casimiro, Sandra, Quintela, António, Fernandes, Afonso, Ramos, Madalena, Costa, Luís
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514972/
https://www.ncbi.nlm.nih.gov/pubmed/23226698
http://dx.doi.org/10.2147/OTT.S36330

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514972/
https://www.ncbi.nlm.nih.gov/pubmed/23226698
http://dx.doi.org/10.2147/OTT.S36330

Ejemplares similares